In a 21.5‑kg child, how many milliliters of 0.9% sodium chloride (PNSS) should the 5.4 mL potassium‑chloride solution be diluted into for a two‑hour infusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Potassium Chloride Dilution for Pediatric Infusion

For a 21.5-kg child receiving 5.4 mL of potassium chloride solution over 2 hours, dilute the KCl in 100 mL of 0.9% sodium chloride (PNSS).

Rationale and Calculation

The FDA-approved potassium chloride labeling emphasizes that administration must occur "only with a calibrated infusion device at a slow, controlled rate" and recommends central venous administration whenever possible for proper dilution 1. The key safety principle is avoiding concentrated potassium infusions that can cause life-threatening arrhythmias and cardiac arrest.

Determining Safe Concentration

For pediatric patients, the evidence supports:

  • Maximum safe infusion rate: 0.5 mEq/kg/hour for routine correction 2
  • Concentration guidelines: Studies demonstrate safety with concentrations up to 200 mEq/L (0.2 mEq/mL) in children when properly monitored 3
  • Volume considerations: Pediatric cardiac patients safely received 0.5 mEq/kg over 2 hours using controlled infusion 2

Practical Application

Assuming standard KCl concentration (2 mEq/mL):

  • 5.4 mL contains approximately 10.8 mEq of potassium
  • For a 21.5-kg child over 2 hours: 10.8 mEq ÷ 2 hours = 5.4 mEq/hour
  • This equals 0.25 mEq/kg/hour (5.4 ÷ 21.5), which is well within safe limits

Dilution volume: Adding 5.4 mL KCl to 100 mL of 0.9% NS creates a final concentration of approximately 102 mEq/L, which is safe for peripheral administration and allows precise 2-hour infusion control.

Critical Safety Measures

Monitoring Requirements

The FDA label and pediatric guidelines mandate 1, 2:

  • Use calibrated infusion pump (never gravity drip)
  • Measure serum potassium 15-30 minutes before and after infusion
  • Monitor ECG if baseline potassium <3.0 mEq/L
  • Check vital signs during infusion

Administration Route

Peripheral access is acceptable for this concentration and rate, though central access is preferred for concentrations >200 mEq/L 1. The dilution to ~100 mEq/L in 100 mL total volume provides adequate safety margin for peripheral administration.

Common Pitfalls to Avoid

  1. Never administer undiluted KCl - Multiple studies document elimination of undiluted KCl as a critical safety intervention 4, 5
  2. Do not exceed 0.5 mEq/kg/hour without continuous ECG monitoring and more frequent potassium checks 1, 2
  3. Avoid adding supplementary medications to the KCl solution 1
  4. Do not use flexible containers in series - risk of air embolism 1

Alternative Considerations

If the child requires faster correction (serum K+ <2.0 mEq/L with ECG changes), rates up to 0.25 mEq/kg/hour using 200 mEq/L concentration have proven safe under close monitoring 3. However, this requires:

  • Continuous ECG monitoring
  • Hourly potassium measurements
  • Preferably central venous access

The 100 mL dilution volume balances safety with practical fluid management for a 21.5-kg child, avoiding excessive fluid administration while maintaining safe potassium concentration and infusion rate 6, 2.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.